These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30929573)

  • 1. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
    Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
    Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Mussazhanova Z; Akazawa Y; Matsuda K; Shichijo K; Miura S; Otsubo R; Oikawa M; Yoshiura K; Mitsutake N; Rogounovitch T; Saenko V; Kozykenova Z; Zhetpisbaev B; Shabdarbaeva D; Sayakenov N; Amantayev B; Kondo H; Ito M; Nakashima M
    Endocr J; 2016 May; 63(5):457-67. PubMed ID: 26935218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis.
    Nakashima M; Suzuki K; Meirmanov S; Naruke Y; Matsuu-Matsuyama M; Shichijo K; Saenko V; Kondo H; Hayashi T; Ito M; Yamashita S; Sekine I
    Int J Cancer; 2008 Mar; 122(5):1082-8. PubMed ID: 17985346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 53BP1 expression as a biomarker to differentiate thyroid follicular tumors.
    Sato A; Matsuda K; Motoyama T; Mussazhanova Z; Otsubo R; Kondo H; Akazawa Y; Higuchi M; Suzuki A; Hirokawa M; Miyauchi A; Nagayasu T; Nakashima M
    Endocr Connect; 2021 Mar; 10(3):309-315. PubMed ID: 33617469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability.
    Naruke Y; Nakashima M; Suzuki K; Matsuu-Matsuyama M; Shichijo K; Kondo H; Sekine I
    Cancer Sci; 2008 May; 99(5):946-51. PubMed ID: 18380789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis.
    Matsuda K; Miura S; Kurashige T; Suzuki K; Kondo H; Ihara M; Nakajima H; Masuzaki H; Nakashima M
    Histopathology; 2011 Sep; 59(3):441-51. PubMed ID: 22034884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
    Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
    Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma.
    Matsuda K; Akazawa Y; Yamaguchi Y; Mussazhanova Z; Kurohama H; Ueki N; Kohno M; Fukushima A; Kajimura I; Hiraki H; Matsuwaki T; Kawashita S; Kinoshita A; Nakashima M
    Pathol Res Pract; 2019 Nov; 215(11):152640. PubMed ID: 31570279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
    Mussazhanova Z; Matsuda K; Naruke Y; Mitsutake N; Stanojevic B; Rougounovitch T; Saenko V; Suzuki K; Nishihara E; Hirokawa M; Ito M; Nakashima M
    Histopathology; 2013 Nov; 63(5):726-34. PubMed ID: 24004175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Endogenous DNA Double-strand Breaks in Oral Squamous Epithelial Lesions by P53-binding Protein 1.
    Imaizumi T; Matsuda K; Tanaka K; Kondo H; Ueki N; Kurohama H; Otsubo C; Matsuoka Y; Akazawa Y; Miura S; Nakashima M
    Anticancer Res; 2021 Oct; 41(10):4771-4779. PubMed ID: 34593426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number variations characterize benign and malignant thyroid tumors.
    Liu Y; Cope L; Sun W; Wang Y; Prasad N; Sangenario L; Talbot K; Somervell H; Westra W; Bishop J; Califano J; Zeiger M; Umbricht C
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E558-66. PubMed ID: 23345095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract.
    Luong TMH; Matsuda K; Niino D; Kurohama H; Ito M; Nakashima M
    Sci Rep; 2021 Feb; 11(1):3074. PubMed ID: 33542453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
    Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
    Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component.
    Ueda M; Matsuda K; Kurohama H; Mussazhanova Z; Sailaubekova Y; Kondo H; Shimizu T; Takada N; Matsuoka Y; Otsubo C; Sato S; Yamashita H; Kawakami A; Nakashima M
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.